Bastide Le Confort Médical SA (EPA:BLC) Just Reported, And Analysts Assigned A €27.00 Price Target
Bastide Le Confort Médical SA (EPA:BLC) came out with its yearly results last week, and we wanted to see how the business is performing and what industry forecasts think of the company following this report. The result was fairly weak overall, with revenues of €482m being 4.9% less than what the analyst had been modelling. Following the result, the analyst has updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we collected the latest post-earnings statutory consensus estimate to see what could be in store for next year.
Taking into account the latest results, the consensus forecast from Bastide Le Confort Médical's one analyst is for revenues of €505.0m in 2027. This reflects a reasonable 4.7% improvement in revenue compared to the last 12 months. Yet prior to the latest earnings, the analyst had been anticipated revenues of €499.0m and earnings per share (EPS) of €1.72 in 2027. So we can see that while the consensus made no real change to its revenue estimates, it also no longer provides an earnings per share estimate. This suggests that revenues are what the market is focusing on after the latest results.
Check out our latest analysis for Bastide Le Confort Médical
The average price target fell 30% to €27.00, withthe analyst clearly having become less optimistic about Bastide Le Confort Médical'sprospects following its latest earnings.
Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The analyst is definitely expecting Bastide Le Confort Médical's growth to accelerate, with the forecast 4.7% annualised growth to the end of 2027 ranking favourably alongside historical growth of 1.2% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 5.6% annually. Bastide Le Confort Médical is expected to grow at about the same rate as its industry, so it's not clear that we can draw any conclusions from its growth relative to competitors.
The Bottom Line
The most important thing to take away is that the analyst reconfirmed their revenue estimates for next year, suggesting that the business is performing in line with expectations. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. Furthermore, the analyst also cut their price targets, suggesting that the latest news has led to greater pessimism about the intrinsic value of the business.
We have estimates for Bastide Le Confort Médical from one covering analyst, and you can see them free on our platform here.
Plus, you should also learn about the 3 warning signs we've spotted with Bastide Le Confort Médical (including 1 which is significant) .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.